ENTITY
Regulus Therapeutics

Regulus Therapeutics (RGLS US)

2
Analysis
Health CareUnited States
Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat and prevent hepatitis C infections, cardiovascular, fibrosis, oncology, immuno-inflammatory, and metabolic diseases. Regulas Therapeutics offers its services worldwide.
more
Company Presentation29 Jan 2025 21:30
Company Presentation24 Jun 2024 20:30
Company Presentation20 Sep 2023 20:30
Company Presentation07 Sep 2023 19:00
Company Presentation06 Sep 2023 23:00
x